Key Metrics of Seer, Inc
Revenue$16.7M▲ 7.5% YoYFY 2023
Operating income−$103M▼ 6.4% YoY
Net profit−$86.3M▲ 7.2% YoY
Shareholders' equity$397M
Market cap$107MSEER · $1.94
About Seer, Inc
Company details
- Website
- seer.bio
- Founded
- 2020
- Listed
- Nasdaq: SEER (since 2020)
Company summary
Legal nameSeer Inc.
TickerSEER
ExchangeNasdaq
CountryUnited States
SEC CIK0001726445
Listed since2020
IndustryBiotechnology: Laboratory Analytical Instruments
SectorOther Industries · Discovered Companies
Websitehttps://seer.bio
US market & SEC filings
SEER · Nasdaq · SEC CIK 0001726445
Last price · 31 Oct 2026
$1.94
−2.51%
Market cap$107M
P/E—On FY 2023 diluted EPS
Volume177,567
SectorIndustrialsBiotechnology: Laboratory Analytical Instruments
Country · IPOUnited StatesListed 2020
SEER share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeRedwood City
GSTIN—
Email—
Websitehttps://seer.bio
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.